Cost-effectiveness of antihypertensive therapy: What message to patients, doctors and health services?

Journal of Hypertension, Supplement

Volumn 16, Issue 9, 1998, Pages

  Zanchetti, Alberto ^a,b  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b Centro di Fisiologia Clinica e Ipertensione   (Italy)

Author keywords

Antihypertensive therapy; Cost effectiveness assessment; Long term benefits; Randomized trials; Short term benefits

Indexed keywords

EID: 4243591428     PISSN: 09521178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Zanchetti A. Presidential lecture. Antihypertensive therapy. Pride and prejudice. J Hypertens 1995; 13:1522-1528.
2. Zanchetti A, Mancia G. Benefits and cost-effectiveness of antihypertensive therapy. The actuarial versus the intervention trial approach. J Hypertens 1996; 14:809-811.
3. Core Services Committee. Guidelines for the management of mildly raised blood pressure in New Zealand. Wellington: Ministry of Health; 1995.
4. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K together with members of the Task Force. Prevention of coronary heart disease in clinical practice. Summary of recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. J Hypertens 1998, 16:1407-1414.
5. Anderson KM, Wilson PWF, Odell PM, Kannel WB. An updated coronary risk profile. A statement of health professionals. Circulation 1991; 83:356-362.
6. Zanchetti A, Mancia G. Strategies for antihypertensive treatment decisions: how to assess benefits? J Hypertens 1997; 15:215-216.
7. Simpson FO. Guidelines for antihypertensive therapy: problems with a strategy based on absolute cardiovascular risk. J Hypertens 1996; 14:863-869.
8. Swales JD. Economics and the treatment of hypertension. J Hypertens 1995; 13:1357-1361.
9. Chatellier G, Ménard J. The absolute risk as a guide to influence the treatment decision-making process in mild hypertension. J Hypertens 1997; 15:217-219.
10. World Health Organization/International Society of Hypertension Guidelines Sub-Committee. 1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993; 11:905-918.
11. World Health Organization Expert Committee. Hypertension Control. WHO Technical Report Series 862. Geneva: World Health Organization; 1996.
12. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
13. Linjer E, Hansson L. Underestimation of the true benefits of antihypertensive treatment: an assessment of some important sources of error. J Hypertens 1997; 15:221-225.
14. Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reduction in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335:827-838.
15. Collins R, Peto R. Antihypertensive drug therapy: effects on stroke and coronary heart disease. In: Swales JD (editor): Textbook of hypertension. Oxford: Blackwell Scientific Publications; 1994. pp. 1156-1164.
16. Zanchetti A. Goals of antihypertensive treatment: prevention of cardiovascular events and prevention of organ damage. Blood Pressure 1992; 1:205-211.
17. Metropolitan Life Insurance Company. Blood pressure: insurance experience and its implications. New York: Metropolitan Life Insurance Company; 1961.
18. Johannesson M. The cost-effectiveness of hypertension treatment in Sweden. Pharmacoeconomics 1995; 7:242-250.
19. Sytkowski PA, D'Agostino RB, Belanger AJ, Kannel WB. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality: the Framingham Heart Study 1950-1990. Circulation 1996; 93:697-703.